SC-24 IMPROVEMENT OF HUMAN MESENCHYMAL STEM CELL HOMING IN DELIVERY OF THERAPEUTIC AGENTS TO GLIOMA STEM CELL XENOGRAFTS

There is an urgent need to develop novel delivery methods for brain tumors. To this end, we have developed human bone marrow mesenchymal stem cells (MSCs) to overcome the problems associated with traditional therapeutic treatments. Compared with other cellular delivery systems, MSCs may be easily ac...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:Neuro Oncol
Main Authors: Nilsson, Carol L., Wildburger, Norelle C., Gumin, Joy, Kroes, Roger A., Moskal, Joseph R., Mechref, Yehia, Lang, Frederick F.
Formato: Artigo
Idioma:Inglês
Publicado: Oxford University Press 2014
Assuntos:
Abstracts
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC4218584/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/neuonc/nou275.24
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares